FDA Approves Exaglo (hydromorphone HCl) Extended-Release Tablets
Links shared publicly online about this topic.
- 1,343total visits
FDA Approves Exaglo (hydromorphone HCl) Extended-Release Tablets
View full resource at drugs.com
Tags: Pain Medication, Pain, FDA, Dilaudid
Most Recently Shared on March 2, 2010 at 11:56 pm By:
FDA Approves Exaglo (hydromorphone HCl) Extended-Release Tablets - http://bit.ly/b7qYjy
FDA Approves Exalgo™ Extended-Release Tablets
medicalnewstoday.com — “CombinatoRx, Incorporated (NASDAQ: CRXX) announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Exalgo™ (hydromorphone HCl) extended-relea” View full resource at medicalnewstoday.com
Most Recently Shared on March 4, 2010 at 4:12 pm By:
MNT Pain News Pain Management and Health News
FDA Approves Exalgo™ Extended-Release Tablets http://mnt.to/3ysf #pain
Exalgo approved for moderate to severe pain - MPR
empr.com — “The FDA has approved Exalgo (hydromorphone HCl extended-release tablets, from Covidien) for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.” View full resource at empr.com
Most Recently Shared on March 2, 2010 at 4:03 pm By:
MPR News: Exalgo approved for moderate to severe pain: The FDA has approved Exalgo (hydromorphone HCl extended-rel... http://bit.ly/cMLPEJ
Exalgo approved for moderate to severe pain - ONA
oncologynurseadvisor.com — “The FDA has approved Exalgo (hydromorphone HCl extended-release tablets, from Covidien) for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 2, 2010 at 3:58 pm By:
OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education
Exalgo approved for moderate to severe pain http://goo.gl/fb/f7t2
FDA provides feedback on the pending NDA for EXALGO tablets
news-medical.net — “CombinatoRx, Incorporated and Neuromed Pharmaceuticals Inc., a privately-held biopharmaceutical company, today announced that on November 13, 2009, representatives of Neuromed discussed the pending New Drug Application (NDA) for the product candidate EXALGOTM (hydromorphone HCl extended release) tablets, seeking FDA approval for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time, with staff ” View full resource at news-medical.net
Most Recently Shared on November 17, 2009 at 10:11 am By:
Epilepsy News: FDA provides feedback on the pending NDA for EXALGO Tablets: CombinatoRx, Incorpor.. http://digg.com/u1GWru
Advertisement
